ScholarIQanswers from OpenAlex
Low-dose melphalan for treatment of high-risk myelodysplastic syndromes.
PaperCitations, authors & open-access status
Low-dose melphalan for treatment of high-risk myelodysplastic syndromes. is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Low-dose melphalan for treatment of high-risk myelodysplastic syndromes. have?
ScholarIQcitation count
Low-dose melphalan for treatment of high-risk myelodysplastic syndromes. has 47 citations in the OpenAlex counts ScholarIQ stores.
When was Low-dose melphalan for treatment of high-risk myelodysplastic syndromes. published?
ScholarIQyear
Low-dose melphalan for treatment of high-risk myelodysplastic syndromes. has 1996 year in the ScholarIQ index.
What is the open-access status of Low-dose melphalan for treatment of high-risk myelodysplastic syndromes.?
ScholarIQoa status
Low-dose melphalan for treatment of high-risk myelodysplastic syndromes. has closed oa status in the ScholarIQ index.
What is the PMID of Low-dose melphalan for treatment of high-risk myelodysplastic syndromes.?
ScholarIQpmid
The PMID for Low-dose melphalan for treatment of high-risk myelodysplastic syndromes. is on the source record.
What is the OpenAlex record for Low-dose melphalan for treatment of high-risk myelodysplastic syndromes.?
ScholarIQopenalex
The OpenAlex for Low-dose melphalan for treatment of high-risk myelodysplastic syndromes. is on the source record.